Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G/Cygnus

This article was originally published in The Tan Sheet

Executive Summary

Announce agreement under which P&G will have exclusive worldwide marketing rights to "at least two" smoking cessation products currently being developed by Cygnus. The deal does not apply to the Nicotrol nicotine patch, which is being marketed in the U.S. and Canada by McNeil Consumer under a recent pact with Cygnus' licensee Kabi Pharmacia ("The Tan Sheet" Jan. 24, p. 13). Cygnus and P&G have a pre-existing agreement to market an OTC using a nontransdermal Cygnus delivery system
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082435

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel